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S_nuuy Using flow cytometric DNA analysis of paraffin embedded tissue, DNA histograms were
successfully obtained from the anal cancers of 117 patients. DNA diploid patterns were given by 82 cancers
(70%) and DNA non-diploid patterns by 35 cancers (30%): 15 DNA aneuploid, 20 DNA tetraploid. Well
differentiated squamous cell cancers were mainly DNA diploid, while a larger proportion of poorly
differentiated and small cell cancers were DNA non-diploid. The large majority of stage A cancers were DNA
diploid. A greater proportion of tumours that had invaded through the anal sphincter or had lymph node
metastases or distant spread were DNA non-diploid. Prognosis was slightly poorer for patients with DNA
non-diploid cancers when compared to patients with DNA diploid tumours (P=0.08) and significantly poorer
for individuals with DNA aneuploid anal cancers (P=0.037). However, in a multivariate analysis model, the
DNA ploidy pattern of an anal cancer was not of independent prognostic significance alongside tumour
histology and tumour stage.
Carcinoma of the anal canal is an uncommon malignancy,
accounting for only 1-3% of colorectal cancers (Goligher,
1984). Flow cytometric DNA analysis has attracted interest
as a possible prognostic tool in patients with colorectal
cancer (Wolley et al., 1982; Armitage et al., 1985; Kokal et
al., 1986; Quirke et al., 1987; Scott et al., 1987a,b). By
contrast, no similar role has been claimed for flow cyto-
metric DNA analysis in patients with an anal canal cancer.
We successfully produced DNA ploidy histograms from
the anal canal cancers of 117 patients. Our aim was to
discover whether the DNA ploidy pattern of an anal canal
cancer is related to clinicopathological features of this malig-
nancy and or patient prognosis.
Materials and methods
Patients with an anal canal cancer treated primarily at the
Mayo Clinic between January 1950 and December 1981 were
considered eligible for this study. The total group numbered
220 patients and included 188 patients previously reported
(Boman et al., 1984) along with 32 more recent cases. Anal
canal cancers arose in the surgical anal canal between the
anal verge and the puborectalis muscle. Carcinomas of the
lower rectum and perianal skin were excluded.
As described previously (Boman et al., 1984) a single
pathologist (L.H.W.) determined the stage and histological
type of each anal canal cancer. Squamous cell carcinomas
were further subdivided into grade I (75-100% of the cells
similar to the parent cell of origin), grade II (differentiation
in 50}75% of cells). grade III (differentiation in 25-50% of
cells) and grade IV tumours (differentiation in 0-25% of
cells). Distant metastatic disease, when present, was also
recorded. Details of patient age at diagnosis along with the
sex of each patient were collected. In addition, the size of the
tumour was available for most patients. Patient survival 5
years after diagnosis along with the initial site of any tumour
recurrence was ascertained.
A 40ym thick section was cut from the original paraffin
embedded block of the anal cancer. This was processed to
give a suspension of cell nuclei (Hedley et al., 1983) which
was stained with propidium iodide (Vindelov et al., 1983). A
DNA histogram was produced by running the stained sus-
pension on a FACS IV flow cytometer.
Fifty-seven of the 220 eligible patients did not have
sufficient paraffin embedded tissue available for analysis, and
so they were excluded. The anal cancer tissue of an addi-
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tional 28 patients had been fixed continuously in formalin
for a penrod of several years. As the tumour tissue of these
28 patients would not stain satisfactonrly with propidium
iodide (Schutte et al., 1985), they also had to be excluded
from the study.
A DNA histogram was obtained from the anal cancers of
135 patients. DNA histograms with a single GO GI peak
were classified as DNA diploid. A DNA diploid ploidy
pattern was given by 82 anal canal cancers (cv of GO/GI
peak 7.95%).DNA histograms that contained an additional
GO/GI peak with a DNA index (DI) value of between 1.10
and 1.99 were classified as DNA aneuploid (Hiddemann et
al., 1984); this latter pattern was seen in 15 anal cancers.
Finally, DNA ploidy patterns with an especially large G2
peak (mean DI 2.10; s.e.m. 0.05) containing more than 10%
of the measured cell nuclei (Tribukait et al., 1982). in the
absence of aggregation (no 6c peak), were classified as DNA
tetraploid; this category of DNA tetraploid included 20 anal
cancers. The DNA histograms of the remaining 18 anal
carcinomas were of such poor quality that they could not be
classified.
Statistical analyses were carred out using the SAS pro-
cedures (SAS Program Institute, 1986). The program FREQ
was used to test associations of clinicopathological features
of the anal canal cancers with their DNA pattern. All P
values were determined using the Pearson X2 statistic. The
survival curves were generated using the Kaplan-Meier
method (Kaplan & Meier, 1958), and univariate survival
comparisons were made using the log-rank statistic (Mantel
& Haenszel, 1959). Multivariate analyses were done using
the program PHGLM to fit a Cox proportional hazards
model (Cox, 1972). A backward regression was used to find
the most significant factors, variables being eliminated based
on the MLE statistics. This process stopped when all MLE
statistics were significant at the 0.05 level. Two-sided P
values based on the y2 score statistic were used for terms in
the Cox model.
Results
Patient age, sex and tunour size
No association was seen between patient sex and the DNA
ploidy pattern of an anal canal cancer (Table I). Similarly,
little correlation was seen between tumour ploidy and patient
age, although younger patients (less than 45 years) had
proportionately more DNA non-diploid patterns (Table I).
Large anal cancers (greater than 5cm diameter) gave more
DNA non-diploid patterns than smaller anal cancers
(Table I).
Br. J. Cwwer (1989), 60, 56-58ANAL CANAL CARCINOMA 57
Table I Anal cancer and DNA ploidy patterns.
DNA
diploid
No. (0)
Sex
Male
Female
Age (years)
<45
45-65
>65
Tumoursize(cm)
<2
2-3
3-5
>5
Unknown
Histology
Squamous
cell 1-2
Squamous
cell 3-4
Nonkerat.
basaloid
Small cell
Stage
A
Bi
B2
B3
C
D
Unknown
DNA
non-diploid
No. (0)
21 (64) 12 (36) 5
61 (73) 23 (27) 6
4
53
25
20
13
12
2
35
(57)
(72)
(69)
(69)
(65)
(63)
(50)
(78)
3
21
11
9
7
7
2
10
(43) 5
(28) 6
(31) 6
(31)
(35)
(37)
(50)
(22)
5-year
surrival ('0)
53 P=0.2
i5
57 P=0.6
54
S0
56 P=0.2
63
66
33
62
13 (81) 3 (19) 88 P<0.0001
36 (68)
27 (71)
6 (60)
13
13
7
15
24
8
2
(87)
(76)
(78)
(65)
(67)
(57)
(67)
17 (32)
11 (29)
4 (40)
2
4
2
8
12
6
1
(13)
(24)
(22)
(35)
(33)
(43)
(33)
65
59
11
100
75
76
62
53
18
33
P<0.0001
Stage A, confined to the anal epithelium and subepithelial connec-
tive tissue; Bi, invasion into the internal sphincter, B2, invasion into
the external sphincter, B3, invasion into the adjacent pelvic tissues;
C, regional (inguinal or pelvic) lymph node metasases; D, distant
metastatic or unresectable disease.
Tumour histology and stage
The large majority of grade 1 and 2 squamous cell carcino-
mas were DNA diploid. Almost one-third of the grade 3 and
4 squamous cell carcinomas and the non-keratinising basal-
oid carcinomas were DNA non-diploid. Small cell carcino-
mas gave the largest proportion (40%) of DNA non-diploid
patterns (Table I).
Among the 117 anal canal carcinomas, the large majority
of stage A, stage Bl and stage B2 cancers were DNA
diploid. By contrast, nearly one-third of those anal carcino-
mas that had invaded through the sphincter or spread to
lymph nodes were DNA non-diploid (Table I). The largest
proportion of DNA non-diploid patterns was seen in
tumours that had metastasised to distant sites.
Therapy and tumour recurrence
Seventeen patients (15%) of the 117 studied had their anal
carcinoma locally excised, 94 (80%) had abdominoperineal
excision of the rectum. and in six (5%) biopsy or some other
surgical procedure was done. One (7%) of 13 DNA diploid
cancers locally excised suffered a local recurrence. Although
only two DNA non-diploid cancers were treated by local
excision, one (50%) recurred locally. There was little differ-
ence in the rates of local recurrence after abdominoperineal
resection - 32% for DNA diploid anal cancers and 26% for
DNA non-diploid cancers (Table II).
Nineteen patients received radiotherapy along with their
surgical procedure. Local recurrence was less commonly seen
with DNA diploid anal cancers so treated (21%) than with
similarly managed DNA non-diploid cancers - 60% local
recurrence (Table III). Only one patient of the 117 studied
received chemotherapy.
Table II Surgical therapy and tumour recurrence
None Local onlj Distant
No. (Go) No. (Go) No. (0)
Local excision
DNA diploid 13 (86) 1 (7) 1 (7)
DNA non-diploid 1 (50) 1 (50) 0
Abdominoperineal
resection
DNA diploid 36 (57) 20 (32) 7 (11)
DNA non-diploid 19 (61) 8 (26) 4 (13)
Six tumours that underwent only biopsy or some other surgical
procedure are excluded.
Table m Radiotherapy with surgery and tumour recurrence
None Local only Distant
No. (Go) No. (GO) No. (o)
DNA diploid 9 (64) 3 (21) 2 (15)
DNA non-diploid 1 (20) 3 (60) 1 (20)
Patient prognosis
Neither patient age nor patient sex was significantly asso-
ciated with survival (Table I). Patients with the largest anal
cancers (greater than 5cm) had the poorest prognosis.
Tumour histology was strongly associated with patient survi-
val (P<0.0001). The best prognosis was seen for patients
with grade 1 and 2 squamous cell carcinoma, with only an
intermediate prognosis being evident for grade 3 and 4
squamous cell cancers and non-keratinising basaloid carci-
noma. The worse prognosis occurred amongst the 10
patients with small cell anal cancer (Table I). Patient prog-
nosis was also strongly correlated with tumour stage
(P<0.0001) (Table I). Not a single patient with stage A
disease died. Survival of the other patients worsened as the
tumour progressively invaded into and through the anal
sphincter or spread to regional lymph nodes or to distant
metastatic sites (Table I).
Patients with a DNA diploid anal cancer had a survival
advantage (66% alive at 5 years) over patients with a DNA
non-diploid anal cancer (52% alive at 5 years) (P=0.08)
(Figure la). Of the DNA non-diploid anal cancers, those
with a DNA aneuploid histogram were associated with the
poorest prognosis - 43% alive at 5 years, P=0.037
(Figure lb). Among grade 1 and 2 squamous cell cancers,
non-keratinising basaloid cancers, and small cell cancers,
there was a trend for DNA non-diploid cancers to have the
poorest prognosis. Little prognostic effect was seen for DNA
ploidy pattern among grade 3 and 4 squamous cell tumours.
Similarly, tumour DNA ploidy pattern was not associated
with any prognostic differences in patients with a stage B
anal cancer. In patients with stage C or stage D anal cancer,
DNA non-diploid cancers tended to be associated with the
worst prognosis, but this never reached statistical
significance.
Multivariate analysis was performed for all 117 patients.
The variables considered were patient sex, patient age,
tumour histology, tumour stage and DNA ploidy pattern.
The independent prognostic vanrable of greatest significance
in this analysis was the tumour cell histology type, small cell
cancer. The DNA ploidy pattern of an anal cancer was not
of independent prognostic significance.
Dison
The 117 anal cancer patients described in this report repre-
sent only one-half of the patients considered eligible for
study. Despite the highly selective nature of the group
studied here, the prognostic importance of tumour histology
and stage was again demonstrated (Boman et al., 1984). By
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contrast, the overall prognostic importance of an anal
cancer's DNA ploidy patter was only marginal. In multi-
variate analysis, the DNA ploidy pattern of an anal canal
cancer was-never of independent prognostic significance.
Despite this latter finding, DNA aneuploid anal cancers
were associated with a poor prognosis in this study. How-
ever, they accounted for only 13% of all anal cancers, an
incidence much lower than that reported for colorectal
adenocarcinomas (Armitage et al., 1985). Others using flow
cytometric DNA analysis have failed to demonstrate any
DNA aneuploid histograms in even poorly differentiated
squamous cell carcinomas of the anus (Fenger & Bichel,
1981). By contrast the very different technique and criteria of
photographic cytophotometry classifies most squamous cell
anal cancers as aneuploid (Goldman et al., 1987). But even
with this much higher incidence of aneuploidy, this latter
study could still not demonstrate any correlation between the
ploidy of anal cancers and patient prognosis (Goldman et
al., 1987).
Interestingly, small cell cancers of the anus had both the
worst prognosis here and the highest proportion of the DNA
non-diploid ploidy patterns. This latter finding may be a
reflection of the increased aggressiveness of these small cell
tumours. Similar small cell lung cancers have an even higher
incidence (over 80%) of DNA non-diploid ploidy patterns
(Bunn et al., 1983).
The primary treatment of the large majority of patients in
this study was surgical, in contrast to the modern multi-
modality therapy of anal cancer (Nigro, 1987). Thus, it is
difficult to extrapolate the findings of this study with regard
to DNA ploidy patterns to the present day management of
anal cancers. However, it was noteworthy that local recur-
rence of an anal cancer was more common after local
excision and after combined surgical and radiation treatment
if the cancer was DNA non-diploid.
It may, therefore, be worth including the DNA ploidy
pattern of an anal cancer as a pathological factor in future
prospective trials that seek to evaluate anal cancer treatment
regimens. This would only be possible if the DNA analysis
of anal cancer biopsies was shown to be both feasible and
reproducible.
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